Effectiveness of Virtual Reality in Cancer Patients Undergoing Chemotherapy. Systematic Review

Overview

Journal Int J Cancer

Specialty Oncology

Date 2024 Nov 16

PMID 39548872

Authors

Jorge Juan Alvarado-Omenat

Rocio Llamas-Ramos

Daniel Garcia-Garcia

Marta Correyero-Leon

Emilio Fonseca-Sanchez

Ines Llamas-Ramos

Affiliations

Soon will be listed here.

Abstract

Virtual reality is on the rise and is currently postulated as one of the most innovative and promising techniques in the management of pain and anxiety in cancer patients, in the face of painful processes or the stress involved in chemotherapy treatment. The objective has been to find out the effectiveness of virtual reality in patients undergoing chemotherapy. Several literature reviews were conducted between November 2023 and January 2024 in the Pubmed, Web of Science and PEDro databases. The keywords "virtual reality," "cancer," "oncology," "exercise" and "chemotherapy" were combined using the Boolean operator AND. 641 manuscripts were selected as potential manuscripts and after elimination of duplicates and application of the inclusion and exclusion criteria, six articles comprised the final review sample. Virtual reality has proven to be an effective technique in reducing the anxiety, pain, asthenia and stress suffered by patients diagnosed with cancer and chemotherapy treatment. The distraction generated by this therapeutic modality, with a wide range of scenarios, helps to reduce the painful perception and worry of these procedures. However, there are no standard application guidelines or application protocols that demonstrate the superiority of one technique over another. Virtual reality could be a valid complementary tool in the treatment of patients undergoing chemotherapy, showing positive results in pain reduction, anxiety, stress or asthenia. More studies are needed, with larger sample sizes and long-term follow-ups to establish treatment protocols in relation to the frequency, intensity, duration and periodicity of interventions with virtual reality.

Citing Articles

Usage of Virtual Reality Technology in Physiotherapy in Germany: Results from a Survey.

Elser A, Ohse M, Frankenstein C, Leeuw M, Schiebler S, Schmieder S Bioengineering (Basel). 2025; 12(2).

PMID: 40001626 PMC: 11851382. DOI: 10.3390/bioengineering12020106.

Effectiveness of virtual reality in cancer patients undergoing chemotherapy. Systematic review.

Alvarado-Omenat J, Llamas-Ramos R, Garcia-Garcia D, Correyero-Leon M, Fonseca-Sanchez E, Llamas-Ramos I Int J Cancer. 2024; 156(7):1419-1428.

PMID: 39548872 PMC: 11789450. DOI: 10.1002/ijc.35258.

References

Mendoza T, Wang X, Cleeland C, Morrissey M, Johnson B, Wendt J . The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999; 85(5):1186-96. DOI: 10.1002/(sici)1097-0142(19990301)85:5<1186::aid-cncr24>3.0.co;2-n. View

Badia X, Tort M, Manganelli A, Camps C, Diaz-Rubio E . The burden of cancer in Spain. Clin Transl Oncol. 2018; 21(6):729-734. DOI: 10.1007/s12094-018-1972-7. View

Fabi A, Fotia L, Giuseppini F, Gaeta A, Falcicchio C, Giuliani G . The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient's dream study. Front Oncol. 2022; 12:960387. PMC: 9563848. DOI: 10.3389/fonc.2022.960387. View

Ioannou A, Papastavrou E, Avraamides M, Charalambous A . Virtual Reality and Symptoms Management of Anxiety, Depression, Fatigue, and Pain: A Systematic Review. SAGE Open Nurs. 2021; 6:2377960820936163. PMC: 7774450. DOI: 10.1177/2377960820936163. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Burrai F, Ortu S, Marinucci M, De Marinis M, Piredda M . Effectiveness of Immersive Virtual Reality in People with Cancer Undergoing Antiblastic Therapy: A Randomized Controlled Trial. Semin Oncol Nurs. 2023; 39(4):151470. DOI: 10.1016/j.soncn.2023.151470. View

Hundert A, Birnie K, Abla O, Positano K, Cassiani C, Lloyd S . A Pilot Randomized Controlled Trial of Virtual Reality Distraction to Reduce Procedural Pain During Subcutaneous Port Access in Children and Adolescents With Cancer. Clin J Pain. 2022; 38(3):189-196. PMC: 8823907. DOI: 10.1097/AJP.0000000000001017. View

Schneider S, Hood L . Virtual reality: a distraction intervention for chemotherapy. Oncol Nurs Forum. 2007; 34(1):39-46. PMC: 2121303. DOI: 10.1188/07.ONF.39-46. View

Schneider S, Kisby C, Flint E . Effect of virtual reality on time perception in patients receiving chemotherapy. Support Care Cancer. 2010; 19(4):555-64. PMC: 3673561. DOI: 10.1007/s00520-010-0852-7. View

10.

Chirico A, Maiorano P, Indovina P, Milanese C, Giordano G, Alivernini F . Virtual reality and music therapy as distraction interventions to alleviate anxiety and improve mood states in breast cancer patients during chemotherapy. J Cell Physiol. 2020; 235(6):5353-5362. DOI: 10.1002/jcp.29422. View

11.

Oyama H, Kaneda M, Katsumata N, Akechi T, Ohsuga M . Using the bedside wellness system during chemotherapy decreases fatigue and emesis in cancer patients. J Med Syst. 2000; 24(3):173-82. DOI: 10.1023/a:1005591626518. View

12.

Bray F, Laversanne M, Weiderpass E, Soerjomataram I . The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021; 127(16):3029-3030. DOI: 10.1002/cncr.33587. View

13.

Lewandowski K, Kaniewska M, Rosolowski M, Kucha P, Rydzewska G . The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab. J Clin Med. 2021; 10(12). PMC: 8235083. DOI: 10.3390/jcm10122709. View

14.

Mitchell A, Chan M, Bhatti H, Halton M, Grassi L, Johansen C . Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011; 12(2):160-74. DOI: 10.1016/S1470-2045(11)70002-X. View

15.

GREENE D . Personal stories within virtual environments: creating three experiences in cancer information software. Stud Health Technol Inform. 1999; 58:151-60. View

16.

Bruno R, Wolff G, Wernly B, Masyuk M, Piayda K, Leaver S . Virtual and augmented reality in critical care medicine: the patient's, clinician's, and researcher's perspective. Crit Care. 2022; 26(1):326. PMC: 9593998. DOI: 10.1186/s13054-022-04202-x. View

17.

Alvarado-Omenat J, Llamas-Ramos R, Garcia-Garcia D, Correyero-Leon M, Fonseca-Sanchez E, Llamas-Ramos I . Effectiveness of virtual reality in cancer patients undergoing chemotherapy. Systematic review. Int J Cancer. 2024; 156(7):1419-1428. PMC: 11789450. DOI: 10.1002/ijc.35258. View

18.

Portenoy R, Thaler H, Kornblith A, Lepore J, Kiyasu E, Sobel K . The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994; 30A(9):1326-36. DOI: 10.1016/0959-8049(94)90182-1. View

19.

Nilsson S, Finnstrom B, Kokinsky E, Enskar K . The use of Virtual Reality for needle-related procedural pain and distress in children and adolescents in a paediatric oncology unit. Eur J Oncol Nurs. 2009; 13(2):102-9. DOI: 10.1016/j.ejon.2009.01.003. View

20.

Llamas Ramos I, Llamas Ramos R, Martin Nogueras A, Alvarado Omenat J, Calvo Arenillas J, Sanchez E . Reliability and Validity of the Spanish Version of the Memorial Symptom Assessment Scale in Oncology Patients. J Pain Symptom Manage. 2016; 52(6):884-891. DOI: 10.1016/j.jpainsymman.2016.05.021. View